[ Price : $8.95]
FDA clears a Caputron Medical 510(k) for its mindGear headset for treating depression, insomnia and anxiety.[ Price : $8.95]
FDA approves a Baxalta NDA for Adynovate (antihemophilic factor [recombinant], pegylated), an extended circulating half-life recom...[ Price : $8.95]
Federal Register Notice: FDAs Vaccines and Related Biological Products Advisory Committee will meet 1/14/16 to hear updates on the...[ Price : $8.95]
FDA officials say clinical trial endpoints for investigational gene therapy products intended for treating cancer must be carefull...[ Price : $8.95]
Glades Drugs recalls compounded multivitamin capsules containing high amounts of Vitamin D3 (cholecalciferol) after receiving seve...[ Price : $8.95]
FDA approves a Bristol-Myers Squibb NDA for Empliciti (elotuzumab) for use in combination with two other therapies to treat multip...[ Price : $8.95]
FDA denies an Almatica Pharma petition asking the agency to impose specific bioequivalence requirements on any ANDAs that referenc...[ Price : $8.95]
FDA sends Bristol-Myers Squibb a complete response letter, declining to approve a supplemental BLA for Opdivo (nivolumab) as a sin...